There is no evidence that antiplatelet agents reduce atherosclerotic risk in patients with HF. 沒有任何證據表明，抗血小板制劑降低心衰患者動脈粥樣硬化的危險。
Evidence that particular chemokine pathways may cooperate to promote monocyte accumulation into inflamed tissues, particularly atherosclerotic arteries, is still lacking. 有證據表明特殊趨化因子通路可能促進單核細胞在發炎的組織中聚集，但在動脈粥樣硬化的動脈中缺乏顯著證據。